Stock CLN CELON PHARMA S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Celon Pharma S.A.

Equities

CLN

PLCLNPH00015

Market Closed - Warsaw S.E.
Other stock markets
 11:55:43 2024-04-26 am EDT 		5-day change 1st Jan Change
15.24 PLN +1.87% Intraday chart for Celon Pharma S.A. +3.11% -1.42%
Apr. 24 Celon Pharma S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Celon Pharma S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
The results of CPL’36 – PDE10a inhibitor to be presented in the poster session at Neuroscience 2021.
PU
Celon Pharma S.A. at the Jefferies Healthcare Conference 2021.
PU
Celon Pharma S A : Doubled export sales, continuation of the strategy of investing in research and development
PU
Celon Pharma S A : 3 posters to be published at 34th ECNP Congress
PU
Celon Pharma S A : at EASD 2021
PU
Celon Pharma S A : Dynamic export and continuation of positive trends in the development of innovative products
PU
Celon Pharma S A : Capital Markets Day – 21.04.2021
PU
Celon Pharma S A : in the Stock Exchange Company of the Year ranking
PU
Celon Pharma S A : Announces Successful Completion of Phase 1A Trial of CPL’116, JAK-ROCK Inhibitor.
PU
Celon Pharma S A : at Top Picks by Trigon Investor Conference
PU
Celon Pharma S A : at J.P. Morgan Annual Healthcare Conference DIGITAL 11-14 January 2021 .
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CLN Stock
  4. News Celon Pharma S.A.
  5. Press Releases